Skip to main content
. 2012 Dec;16(Suppl 2):S474–S476. doi: 10.4103/2230-8210.104136

Table 2.

Assessed groupwise parameters at 24 weeks of follow-up on oral anti-diabetic drugs

graphic file with name IJEM-16-474-g002.jpg